NASHVILLE, TN (WSMV) - The Vanderbilt Vaccine center could be just a few months away from producing a short-term treatment for the coronavirus.

Vanderbilt has been working on a treatment they’re calling ‘passive therapy or immunization’ since March. The treatment would use the antibodies from survivors of COVID-19 to treat current patients.

Dr. Robert Carnahan from Vanderbilt said they’ve already identified a large panel of antibodies that could be used to protect against COVID-19 up front and is cautiously optimistic about the findings.

The center is currently in the process of passing their findings on to several biotech and pharmaceutical partners in order to move forward with producing the antibodies for clinical trials.  

The earliest clinical trials could be expected to begin some time in July or August.

Follow News4 for the latest updates to this story. 

WSMV.com is now with you on the go! Get the latest news updates and video, 4WARN weather forecast, weather radar, special investigative reports, sports headlines and much more from News4 Nashville.

>> Click/tap here to download our free mobile app. <<


Copyright 2020 WSMV (Meredith Corporation). All rights reserved.

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.